Vipan Kumar has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the Therapeutic Promise of Naphthoquinones: A Spotlight on Lapachol

    by Amit Lather, Neelam Jain, Tanuj Hooda, Sandeep Kumar, Vipan Kumar, Manish Kumar Gautam, Navidha Aggarwal

    Medicinal plants possess various biological activities and significantly contribute towards the development of various clinically used medications. In recent years, the research interest in natural drug designs has increased exponentially. Lapachol is a useful phytoconstituent with a quinone ring, reported for its broad-spectrum pharmacological activities, including antimicrobial, anticancer, anti-leishmanial, anti-trypanosomal, molluscicidal, wound-healing, and other activities. The therapeutic values of Lapachol from various plant families have been explored in existing scientific reports, as well as in traditional uses and other potential therapeutic effects. This review highlights updates on the pharmacological activities and other traditional uses of Lapachol.

  • Exploring Synthetic Strategies and Therapeutic Potential of Naphthoquinone Derivatives: A Review

    by Mohit Saini, Vipan Kumar, Shilpi Chauhan, Vikas Sharma, Prashant Kumar Dhakad

    Naphthoquinone derivatives are increasingly recognized for their wide‐ranging biological activities and relevance in drug discovery. This review outlines recent advances in the synthesis of naphthoquinone compounds, focusing on strategies that enhance their structural diversity and efficiencies. We explored their broad therapeutic potential, including strong antimicrobial effects against both gram‐negative and gram‐positive pathogens and their capacity to overcome microbial resistance. Their antimalarial activity also shows promise, offering new options for the treatment of drug‐resistant species. In oncology, several derivatives have demonstrated selective cytotoxicity against cancer cell lines, with distinct mechanisms supporting their development as anticancer agents. Additionally, their antioxidant properties offer protection against oxidative stress, which has implications for chronic diseases and aging‐related disorders. Emerging data also indicate neuroprotective effects, particularly in Alzheimer's disease, by modulating oxidative stress and neuroinflammation. These findings underscore the versatility of naphthoquinone derivatives as potential leads in multiple therapeutic areas. By compiling synthetic methods and biological insights, this review provides a comprehensive resource to support future research and the development of naphthoquinone‐based drug candidates.


  • Open Access

    Amphiphilic, lauric acid-coupled pluronic-based nano-micellar system for efficient glipizide delivery

    by Vipan Kumar, Neelam Poonia, Pradeep Kumar, Prabhakar Kumar Verma, Abdulrahman Alshammari, Norah A. Albekairi, Atul Kabra, Neera Yadav

    Glipizide; an insulin secretagogue belonging to the sulfonylurea class, is a widely used antidiabetic drug for managing type 2 diabetes. However, the need for life-long administration and repeated doses poses challenges in maintaining optimal blood glucose levels. In this regard, orally active sustained-release nano-formulations can be a better alternative to traditional antidiabetic formulations. The present study explored an innovative approach by formulating orally active sustained-release nano-micelles using the amphiphilic lauric acid-conjugated-F127 (LAF127) block copolymer. LAF127 block copolymer was synthesized through esterification and thoroughly characterized before being employed to develop glipizide-loaded nano-micelles (GNM) via the thin-film hydration technique. The optimized formulation exhibited mean particle size of 341.40 ± 3.21 nm and depicted homogeneous particle size distribution with a polydispersity index (PDI) < 0.2. The formulation revealed a surface charge of −17.11 ± 6.23 mV. The in vitro release studies of glipizide from developed formulation depicted a sustained release profile. Drug loaded micelles exhibited a substantial reduction in blood glucose levels in diabetic rats for a duration of up to 24 h. Notably, neither the blank nano-micelles of LAF127 nor the drug loaded micelles manifested any indications of toxicity in healthy rats. This study provides an insight on suitability of synthesized LAF127 block copolymer for development of effective oral drug delivery systems for anti-diabetic activity without any significant adverse effects.


  • Pyridazinones: A versatile scaffold in the development of potential target‐based novel anticancer agents

    by Jyoti Singh, Vipan Kumar, Pragati Silakari, Sandeep Kumar

    Pyridazinones are important nitrogen‐rich heterocyclic core that has been driving the substantial medicinal interest due to their wide range of biological activities. This privileged scaffold forms a central core in numerous potent compounds, which results in the development of novel anticancer drugs with fruitful biological activities. The current review article summarizes the progressive development of novel pyridazinone derivatives that are targets for numerous receptors such as C‐met kinase inhibitors, PARP inhibitors, Tubulin polymerization inhibitors, Dihydro folate reductase inhibitors, B‐Raf inhibitors, Bruton tyrosine kinase inhibitors, FER tyrosine kinase inhibitors, and fibroblast growth factors receptors. It features the various simple techniques for the synthesis of pyridazinones and also highlights the mechanistic insights into the anticancer properties of pyridazinone derivatives.


  • Synthesis and antimycobacterial evaluation of pyrazinamide, benzimidazole and carboxamide derivatives

    by Rashmi Shah, Prabhakar Kumar Verma, Manisha Shah, Vipan Kumar

    Due to the unusual structure and chemical composition of the mycobacterial cell wall, it is difficult to develop effective antitubercular treatment as it leads to many antibiotics not working and preventing drug entry. It also leads to the problem of more drug resistance. Tuberculosis (TB) is still the second most contagious disease with about 33% of the world's population being affected mainly by drug‐resistant TB (MDR, XDR), chronic infections, and the combination of TB and human immunodeficiency virus (HIV). Therefore, there is an urgent need for the development of novel antitubercular drugs that will shorten the total duration of effective treatment taken under directly observed treatment, short‐course (DOTS) guidance, solve the problem of multiple drug resistance, and provide effective treatment for TB diseases. In this review, we considered various synthetic schemes of pyrazinamide, benzimidazole, and carboxamide derivatives that have antitubercular properties that can overcome the resistance to parental drugs and thus act as an effective alternative.


  • New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments

    by Vipan Kumar, Amruta Suryan, Jyoti Singh, Sandeep Kumar, Pradeep Kamboj, Aakash Deep

    Since December 2019, the prevalence of novel coronavirus infection (named as COVID- 19 by WHO on Feb 11, 2020) has become a growing healthcare concern worldwide. On March 11, 2020, the WHO declared COVID-19 a global pandemic. As no specific approved treatment options are available for the COVID-19 infection, several existing antiviral drugs in combination with others have become the mainstay therapy. The targets for the treatment of the infection include viral targets such as polymerases, spike glycoproteins, membrane proteins, and viral envelope and host targets such as host proteases and host receptors. Antiviral agents, immunomodulatory agents, and empiric broad-spectrum antibiotics can be used as treatment therapies for the infection. Convalescent plasma therapy has also been proposed as an effective treatment for COVID-19. Additionally, many studies are ongoing to develop a potent and effective vaccine that completely blocks SARS-CoV-2. Nevertheless, prevention of spread of the virus remains the first and foremost step towards controlling and managing the coronavirus infection.

  • Synthesis, Antimicrobial, and Antioxidant Screening of Aryl Acetic Acid Incorporated 1,2,4‐Triazolo‐1,3,4‐Thiadiazole Derivatives

    by Vipan Kumar Kamboj, Archana Kapoor, Sandeep Jain

    Some novel [1,2,4]triazolo[3,4‐b][1,3,4]thiadiazole derivatives were synthesized from aryl acetic acids. All the synthesized derivatives were selected for the screening of antibacterial potential against Gram‐positive bacteria [Staphylococcus aureus (MTCC 3160) and Micrococcus luteus (MTCC 1538)] and Gram‐negative bacteria [Escherichia coli (MTCC 1652) and Pseudomonas aeruginosa (MTCC 424)] and antifungal potential against Aspergillus niger (MTCC 8652) and Candida albicans (MTCC 227), and free radical scavenging activity through 2,2‐diphenyl‐2‐picrylhydrazyl hydrate method. The compounds TH‐4, TH‐13, and TH‐19 were found to be more potent antimicrobial agents compared to standard drugs. The compounds TH‐3, TH‐9, and TH‐18 also showed significant antimicrobial activity. The compound TH‐13 showed antioxidant activity with IC50 value better than the standard compound. The structures of all the synthesized compounds were confirmed by Fourier transform infrared, 1H‐NMR, liquid chromatography–mass spectrometry, and CHN analyzer.


  • Open Access

    PREPARATION AND CHARACTERIZATION OF METFORMIN LOADED STEARIC ACID COUPLED F127 NANOPARTICLES

    by Vipan Kumar Kamboj, Prabhakar Kumar Verma

    Objective: The objective of this study was to prepare and evaluate metformin nanoparticles (MN) using stearic acid-coupled F127 (SAF127) copolymer and polyvinyl alcohol by emulsion solvent evaporation technique.Method: Metformin is the first-line drug for the treatment of type II diabetes mellitus belongs to Biopharmaceutical Classification System Class III. The prepared MN was characterized for particle size, polydispersity index (PDI), zeta potential, drug entrapment, percentage yield, in vitro drug release, and stability studies. The compatibility studies were performed by Fourier transform infrared (FTIR) and differential scanning calorimetry (DSC). The crystallographic and surface properties were studied by X-ray diffractometry and scanning electron microscopy, respectively.Results: The mean particle diameter of prepared nanoparticles ranged from 207.8 to 977.64 nm, PDI value ranged from 0.146 to 0.694, and zeta potential ranged from −20.5 to −6.97 mV. The drug entrapment efficiency of these nanoparticles varies between 18.81 to 69.01 %. The drug to SAF127 copolymer (10/30 w/w) ratio (MN3) showed optimum results. The MN3 had spherical morphology with semi-amorphous nature. The results of FTIR and DSC analysis showed that there was no significant interaction between drug and excipients. The prepared polymeric nanoparticles were stable at 5±3°C up to 3 months. In vitro release of drug from MN3 was 20.52% in the first 1 h and remaining drug was released up to 30 h.Conclusion: The results of this study confirmed the sustained drug release profile of metformin loaded SAF127 copolymer nanoparticles. These nanoparticles can be best stored up to 3 months.


  • Structural and molecular alterations in arsenic-induced hepatic oxidative stress in rats: a FTIR study

    by Chandra Prakash, Vipan Kumar Kamboj, Pooja Ahlawat, Vijay Kumar

    Arsenic (As) is an ubiquitously distributed environmental toxicant predominantly contaminating drinking water. A number of studies indicated that oral exposure of humans to inorganic As produced damage to various body tissues including liver. Oxidative stress is thought to play a major role in As-induced hepatotoxicity. In this study, Fourier transforms infrared (FTIR) spectroscopy approach was applied to determine whether chronic As exposure at 25 ppm, intragastrically for 12 weeks, affected oxidative stress status in rat liver. Data demonstrated that chronic As administration exacerbated oxidative stress as was evidenced by suppressed antioxidant defense system and increased lipid peroxidation and protein oxidation. The FTIR study showed that peak area value of amide A decreased significantly followed by reduced amide I and amide II peak area in an As-treated rat liver suggesting altered protein profile. The change of Olefinic˭CH stretching band and C˭O stretching of triglycerides band indicated the altered lipid levels due to metallic exposure. The fall in the peak area of PO2− asymmetric stretching in the As-treated group might be due to compositional changes of nucleic acids. Hence, the results of this study indicate that As-induced oxidative stress was associated with structural and molecular modifications in proteins, lipids, and glycogen in a rat liver that may help to elucidate molecular mechanisms underlying metal-mediated hepatic damage.